1822-1823 / 2063
Endpoints
•
Tumor regression
non-specific endpoint
•
Tumor regrowth delay
difficult or impossible to
accurately estimate cell kill
•
Local tumor control
•
Aim of curative RT
improvements in LC often
translate into prolonged survival
•
When all clonogenic cells (i.e. cells with the capacity to
proliferate and to cause recurrence after RT) have been
inactivated
16